Mah Sing Healthcare gets nod to market gloves in US


MahSing Group Bhd founder and group managing director Tan Sri Leong Hoy Kum (right) receiving a box of rubber gloves from an employee at the group’s glove manufacturing factory in Kapar, Klang. - File pic/The Star

PETALING JAYA: Mah Sing Group Bhd’s unit has received the green light by the United States Food and Drug Administration (FDA) to market nitrile examination gloves in the US market.

The property developer, which diversified into glove manufacturing this year, said its healthcare business unit, Mah Sing Healthcare Sdn Bhd, received the 510(K) pre-market notification clearances from the FDA on Dec 4.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Mah Sing Healthcare , sell , gloves , US ,

   

Next In Business News

Khairy Jamaluddin named member of India-based Fischer Medical Ventures board
Ringgit has been unfortunate, unfairly assessed vs US dollar -BNM
Wall St set for muted open as weak earnings offset jobless claims relief
Creador’s Brahmal emerges as substantial shareholder of MCE Holdings
US weekly jobless claims increase more than expected
AmBank launches revamped AmOnline mobile banking
Pentamaster to prioritise sustainability
Kerjaya Prospek Property to jointly develop Batu Kawan land for proposed mixed development
Ringgit almost unchanged against greenback at the close
Malaysia to retain lead in Asia-Pacific Islamic banking market - S&P Global

Others Also Read